PTU-049 Concurrent Immunomodulator Therapy does not Influence Infliximab or Adalimumab Trough Levels During Maintenance Therapy
Bond, A, Fisher, G, Skouras, T, Subramanian, SVolume:
65
Language:
english
Journal:
Gut
DOI:
10.1136/gutjnl-2016-312388.136
Date:
June, 2016
File:
PDF, 59 KB
english, 2016